TED website is eForms ready from today 02/11/2022. Search changed: please adapt your predefined expert queries. Discover the changes in the site news and in the updated Help Pages
EU solidarity with Ukraine
Prozorro+: Ukrainian public procurement platform
Greece-Athens: IT services: consulting, software development, Internet and support
Prior information notice
This notice is for prior information only
Section I: Contracting authority
Section II: Object
‘Innovation procurement for Drug Detection in correctional institutions and prisons’ — DrugDetect
This Prior Information Notice announces an Open Market Consultation and provides information about a planned public procurement of innovative solutions (PPI) carried out by the project ‘Innovation procurement for Drug Detection in correctional institutions and prisons’ — DrugDetect. This project receives co-funding by the COSME programme of the European Union under grant agreement No 101036225.
The DrugDetect project aims to procure an innovative solution for the automatic detection of a large range of drugs in correctional institutions and prisons, that is available 24/7, does not cause delays in internal processes, does not require minimal human intervention, and is GDPR compliant.
This is an announcement of an Open Market Consultation regarding a future public procurement of innovative solutions (PPI).
For the procurement procedure, a competitive procedure with negotiation or a competitive dialogue will be conducted according to the Greek Law (L. 4412/2016). The candidates qualified based on the selection criteria will be invited to participate in the negotiations/dialogue.
The dialogue will take place in two or three rounds, that follow an informative meeting with all the qualified candidates (when candidates are able to request clarifications) and the submission of an
initial proposal. The dialogue rounds will be organised as individual meetings with the qualified candidates. After each individual meeting, the qualified candidates may be invited to update their
initial proposal by the submission of one or more intermediate proposals. During the dialogue, any element of the tender documentation may be discussed with the qualified candidates (except for the
The summary of all questions and related answers will be made available to all qualified candidates, who are still in the race, 10 days before the submission of the intermediary proposal for the next dialogue round. The number of the qualified candidates/proposals may be reduced during the dialogue, based on the award criteria.
At the end of the dialogue phase the qualified candidates shall be invited to present their final proposals.
The best value for money proposal will be evaluated using award criteria such as: technical value of the solution, Cost performance analysis based on the performance evaluation and the TCO evaluation (the most important cost components will be considered), quality of the services related to installation, maintenance and support.
This procurement receives funding under the COSME programme of the EU under grant agreement No 101036225. The EU is however not participating as a contracting authority in this procurement. This PIN is published to announce an OMC on potential future procurement activity and is not a commitment to procure. It doesn't oblige the contracting authority to set limits to the content of the tender.
Section IV: Procedure
Section VI: Complementary information
This PIN invites all interested operators (mainly from EU Member States, associated countries, and WTO GPA signatories, regardless of their size or governance structure) to take part in the Open Market Consultation (OMC).
The Open Market Consultation aims to validate the identified needs and solution design with the supply side, explain clearly how confidentiality/IPR issues will be treated and build trust between potential buyers and providers.
The Open Market Consultation will take the form of:
- An EU Survey with questions for the market parties will be created
-The outcomes will be summarised on the DrugDetect website and other websites requested by the European Commission together with a list of Q&As raised during the open market
- DrugDetect will also organise one Infoday in Brussels, the 7-7-2022, and several webinars to promote the project and several one-on-one dialogue sessions in order to gather feedback and information from the industry regarding the available technologies and solutions of the market.
- A Match making tool will be created on the project website
The Open Market Consultation will be conducted in a hybrid form with the participation of market parties from different European countries. In order to facilitate the participation of European
SMEs and startups, the market consultation shall be designed in a suitable way.
Interested parties are requested to register to participate and where needed sign NDAs in due time.
More information will be made available on the DrugDetect project website (https://drug-detect.eu) and https://ddc2022.b2match.io/
Participation in the OMC will not be a requirement to submit a proposal to the tender, does not lead to any rights or privileges for the participants, and is not part of any pre-qualification or selection process.
The contracting authority involved in the DrugDetect project is not legally bound in any way by the outcome of the market consultation. The open market consultation will provide an overview on the procurement objectives, the PPI process and the main clauses of the contract. It is also not part of any pre-qualification or selection process. No advantage or disadvantage will be given to any supplier / group of suppliers to the detriment of others during the market consultation and the sub-sequent competitive procedure for the award of contracts procurement.
All communication will be carried out in English via the email email@example.com
All information provided during the open market consultation and other background information will be published online in English.